Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-33808

Single-particle
3.0 Å
EMD-33808
3D View Gallery
Deposition: 11/07/2022
Map released: 29/11/2023
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-33808
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7yg5 summary report (pdf.gz) Map and 7yg5 FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the topiramate-bound state

EMD-33808

Single-particle
3.0 Å
EMD-33808
3D View Gallery
Deposition: 11/07/2022
Map released: 29/11/2023
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Human R-type voltage-gated calcium channel CaV2.3-alpha2/delta1-beta1 complex in the topiramate-bound state
Fitted models: 7yg5

Deposition Authors: Gao Y , Zhao Y
Structural insights into the allosteric effects of the antiepileptic drug topiramate on the Ca V 2.3 channel.
Gao Y , Bai Q, Zhang XC, Zhao Y
(2024) Biochem Biophys Res Commun , 725 , 150271 - 150271
PUBMED: 38901222
DOI: doi:10.1016/j.bbrc.2024.150271
ISSN: 1090-2104
ASTM: BBRCA9
Grant Support: